Sort by
Refine Your Search
-
About us University College London (UCL) UCL is a multi-disciplinary university with a population of over 13,000 staff and 42,000 students from 150 different countries. Degree programmes
-
About us University College London (UCL) UCL is a multi-disciplinary university with a population of over 13,000 staff and 42,000 students from 150 different countries. Degree programmes
-
pragmatic multi-centre trials of emerging and established imaging techniques within the NHS that ultimately change clinical practice. Our work is translational in nature, reflecting the interests and
-
support sustainable transitions for people and planet. As a Principal Research Fellow of the Institute, the primary role will be Research Director for the UCL Centre on Net Zero Market Design, which
-
through the UCL–AstraZeneca Centre of Excellence, the programme will appoint six postdoctoral researchers to work across UCL and AstraZeneca sites, combining computational and experimental approaches. UCL
-
About us The UCL Institute for Global Health (IGH) is at the heart of UCL’s Grand Challenge of Global Health. The Institute’s vision is for a world where international policy on global health is
-
of the REFINE-MS trial, a multi-centre, phase 3 study led by Professor Olga Ciccarelli and Professor Max Parmar at UCL. The trial aims to identify the optimal dosing frequency of ocrelizumab in patients with
-
are located in Bloomsbury, at the heart of London, and offer an exciting and vibrant environment in which to study in one of the UK's top universities. The Department of Chemistry at UCL is committed
-
Parkinson’s Disease (EJS ACT-PD) trial is a multi-arm, multi-stage (MAMS) platform trial aiming to increase scale and pace of PD research. The trial provides a sustainable platform to efficiently assess
-
Clinical Trials in Parkinson’s Disease (EJS ACT-PD) trial is a multi-arm, multi-stage (MAMS) platform trial aiming to increase scale and pace of PD research. The trial provides a sustainable platform to